The weekly litigation news digest is live. Subscribe now

IP Verse

Methods Of Reducing The Risk Of A Cardiovascular Event In A Subject On Statin Therapy - EP3363433

The patent EP3363433 was granted to Amarin Pharmaceuticals Ireland on Dec 9, 2020. The application was filed on Jun 28, 2013 under application number EP17206714A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3363433

AMARIN PHARMACEUTICALS IRELAND
Application Number
EP17206714A
Filing Date
Jun 28, 2013
Status
Granted And Under Opposition
Nov 6, 2020
Publication Date
Dec 9, 2020
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (3)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
HOFFMANN EITLESep 9, 2021HOFFMANN EITLE -
COOKESep 7, 2021ELKINGTON AND FIFEADMISSIBLE
ELKINGTON AND FIFESep 3, 2021ELKINGTON AND FIFEADMISSIBLE

Patent Citations (5) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
OPPOSITIONUS2011178105
OPPOSITIONUS2012035262
OPPOSITIONUS2012121698
OPPOSITIONWO2010014799
OPPOSITIONWO2012074930

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents